Liang JL - Search Results

1

Amplifying Ca²⁺ overload by engineered biomaterials for synergistic cancer therapy.

Liang JL, Cao Y, Lv K, Xiao B, Sun J. Liang JL, et al. Biomaterials. 2024 Dec 15;316:123027. doi: 10.1016/j.biomaterials.2024.123027. Online ahead of print. Biomaterials. 2024. PMID: 39700532 Review.

2

Engineered bacterium-metal-organic framework biohybrids for boosting radiotherapy with multiple effects.

Wang JW, Ji P, Zeng JY, Liang JL, Cheng Q, Liu MD, Chen WH, Zhang XZ. Wang JW, et al. Among authors: liang jl. Biomaterials. 2025 Mar;314:122901. doi: 10.1016/j.biomaterials.2024.122901. Epub 2024 Oct 19. Biomaterials. 2025. PMID: 39447307

3

A PD-L1-targeting Regulator for Metabolic Reprogramming to Enhance Glutamine Inhibition-Mediated Synergistic Antitumor Metabolic and Immune Therapy.

Jin XK, Zhang SM, Liang JL, Zhang SK, Qin YT, Huang QX, Liu CJ, Zhang XZ. Jin XK, et al. Among authors: liang jl. Adv Mater. 2024 Feb;36(6):e2309094. doi: 10.1002/adma.202309094. Epub 2023 Dec 6. Adv Mater. 2024. PMID: 38014890

4

Interference of ATP-Adenosine Axis by Engineered Biohybrid for Amplifying Immunogenic Cell Death-Mediated Antitumor Immunotherapy.

Deng XC, Liang JL, Zhang SM, Wang YZ, Lin YT, Meng R, Wang JW, Feng J, Chen WH, Zhang XZ. Deng XC, et al. Among authors: liang jl. Adv Mater. 2024 Sep;36(36):e2405673. doi: 10.1002/adma.202405673. Epub 2024 Jul 18. Adv Mater. 2024. PMID: 39022876

5

Disrupting Intracellular Homeostasis by Copper-Based Nanoinducer with Multiple Enzyme-Mimicking Activities to Induce Disulfidptosis-Enhanced Pyroptosis for Tumor Immunotherapy.

Jin XK, Zhang SK, Zhang SM, Liang JL, Yan X, Lin YT, Meng R, Xu ZH, Liu CJ, Zhang XZ. Jin XK, et al. Among authors: liang jl. Adv Mater. 2024 Oct 29:e2410957. doi: 10.1002/adma.202410957. Online ahead of print. Adv Mater. 2024. PMID: 39468892

6

Immunoadjuvant-Modified Rhodobacter sphaeroides Potentiate Cancer Photothermal Immunotherapy.

Niu MT, Chen QW, Chen Z, Liu X, Huang QX, Liang JL, Zhong Z, Cheng H, Zhang XZ. Niu MT, et al. Among authors: liang jl. Nano Lett. 2024 Jan 10;24(1):130-139. doi: 10.1021/acs.nanolett.3c03191. Epub 2023 Dec 27. Nano Lett. 2024. PMID: 38150297

7

Versatile Nanoplatform Loaded with Doxorubicin and Graphene Quantum Dots/Methylene Blue for Drug Delivery and Chemophotothermal/Photodynamic Synergetic Cancer Therapy.

Liang J, Liu J, Jin X, Yao S, Chen B, Huang Q, Hu J, Wan J, Hu Z, Wang B. Liang J, et al. ACS Appl Bio Mater. 2020 Oct 19;3(10):7122-7132. doi: 10.1021/acsabm.0c00942. Epub 2020 Sep 18. ACS Appl Bio Mater. 2020. PMID: 35019372

8

Dendritic Cell-Based In Situ Nanovaccine for Reprogramming Lipid Metabolism to Boost Tumor Immunotherapy.

Qin YT, Liu XH, An JX, Liang JL, Li CX, Jin XK, Ji P, Zhang XZ. Qin YT, et al. Among authors: liang jl. ACS Nano. 2023 Dec 26;17(24):24947-24960. doi: 10.1021/acsnano.3c06784. Epub 2023 Dec 6. ACS Nano. 2023. PMID: 38055727

9

Engineering metal-based hydrogel-mediated tertiary lymphoid structure formation via activation of the STING pathway for enhanced immunotherapy.

Jin XK, Liang JL, Zhang SM, Ji P, Huang QX, Qin YT, Deng XC, Liu CJ, Zhang XZ. Jin XK, et al. Among authors: liang jl. Mater Horiz. 2023 Oct 2;10(10):4365-4379. doi: 10.1039/d3mh00748k. Mater Horiz. 2023. PMID: 37455643

10

Metabolic Regulation-Mediated Reversion of the Tumor Immunosuppressive Microenvironment for Potentiating Cooperative Metabolic Therapy and Immunotherapy.

Ji P, Jin XK, Deng XC, Zhang SM, Liang JL, Li QR, Chen WH, Zhang XZ. Ji P, et al. Among authors: liang jl. Nano Lett. 2024 Apr 17;24(15):4691-4701. doi: 10.1021/acs.nanolett.4c01307. Epub 2024 Apr 8. Nano Lett. 2024. PMID: 38588212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters